Gabapentin
Brand name: Gabapentin
Rank #61 of 500 drugs by total cost
$291.0M
Total Cost
15,142,335
Total Claims
$291.0M
Total Cost
158,635
Prescribers
$19
Cost per Claim
3,929,716
Beneficiaries
23,679,693
30-Day Fills
$1,835
Avg Cost/Provider
95
Avg Claims/Provider
About Gabapentin
Gabapentin (sold as Gabapentin) was prescribed 15,142,335 times by 158,635 Medicare Part D providers in 2023, costing the program $291.0M. At $19 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 58 | Sitagliptin Phos/Metformin Hcl (Janumet) | $302.2M | 329,315 |
| 59 | Tofacitinib Citrate (Xeljanz Xr) | $294.4M | 49,478 |
| 60 | Umeclidinium Brm/Vilanterol Tr (Anoro Ellipta) | $294.3M | 480,651 |
| 61 | Gabapentin (Gabapentin) | $291.0M | 15,142,335 |
| 62 | Cabozantinib S-Malate (Cabometyx) | $287.3M | 11,285 |
| 63 | Rsv Vacc, Pref A And Pref B/Pf (Abrysvo) | $284.5M | 872,396 |
| 64 | Bimatoprost (Lumigan) | $284.4M | 610,243 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology